IVA – inventiva s.a. - american depository shares (US:NASDAQ)
Stock Stats
News
Inventiva reports preliminary 2025¹ fiscal year financial results
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
Inventiva (NASDAQ:IVA) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Inventiva (NASDAQ:IVA) was given a new $24.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.
Inventiva (NASDAQ:IVA) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Form SCHEDULE 13G/A Inventiva S.A. Filed by: Andera Partners
Form SCHEDULE 13G/A Inventiva S.A. Filed by: Sofinnova Crossover I
Form SCHEDULE 13G/A Inventiva S.A. Filed by: GREAT POINT PARTNERS LLC
Form 6-K Inventiva S.A. For: Feb 17
Form SCHEDULE 13G/A Inventiva S.A. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.